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Hearing impairment is prevalent in the general population; early intervention facilitates proper 
development. 
Aim: To establish the prevalence of hearing impairment in infants at risk, born between June 2006 
and July 2008, and to correlate the variables with hearing loss. 
Type of study: descriptive and cross-sectional. 
Materials and Methods: 188 newborns were evaluated using evoked otoacoustic emissions and 
distortion product and auditory behavior. Tests were repeated if the results were altered. If altered 
results persisted, the child was referred for impedance testing and, when necessary, for medical 
evaluation. Infants with normal conduction were referred for brainstem auditory evoked potential 
testing. 
Results: Of 188 children two (1.1%) were excluded, and 174 (92.6%) had results within normal 
limits. Hearing impairment was found in 12 children (6.3%); hearing loss was retrocochlear in three 
infants (25%). Unilateral hearing loss was present in two infants (16.7%); bilateral hearing loss was 
present in 10 infants (83.3%). 
Conclusion: The high prevalence of hearing impairment in this population underlines the importance 












Brazilian Journal of otorhinolaryngology 76 (6) novemBer/DecemBer 2010
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
Impaired hearing is prevalent in the world popu-
lation. Intervening before the age of 6 months allows for 
normal development of language regardless of the degree 
of hearing loss.1 
This condition may occur in neonates at or not at 
risk. The prevalence in low-risk neonates ranges from 
0.09 to 2.3%;2,3 in the high-risk population it ranges from 
0.3 to 14.1%.4,5 The prevalence of impaired hearing rea-
ches 11% in very low birth weight neonates;6 this study, 
however, included sensorineural, mixed and conduction 
hearing loss. Only 3% of these subjects were given indivi-
dual hearing aids. A study that applied electrophysiology 
methods - evoked otoacoustic emissions - for analyzing 
neonates found a 6.3% rate of hearing impairment in very 
low birth weight infants. Another study that evaluated 
infants in neonatal intensive care units found prevalence 
rates of hearing loss ranging from 3 to 14.1%.5,7
The Joint Committee on Infant Hearing (JCIH) has 
proposed risk indicators to be used internationally,8,9 su-
pplemented by studies to adapt these indicators locally, 
for instance to the Brazilian context.10,11 
The purpose of this study was to verify the preva-
lence of hearing impairment and to correlate it with risk 
indicators in neonates born and monitored at a tertiary 
hospital.
MATERIALS AND METHODS
This descriptive cross-sectional study included neo-
nates weighing 1,500 g or less and a gestational age of not 
more than 34 weeks, admitted to the neonatal intensive 
care unit of a reference hospital. After being discharged, 
these patients were monitored from June 2006 to July 
2008. Patients who did not undergo all tests and did not 
have a final audiological diagnosis during the study period 
were excluded. 
A medical history focused on the risk factors pro-
posed by the JCIH8,9 adapted to the Brazilian context.10-11 
Audiological testing consisted of distortion product evoked 
otoacoustic emissions (DPOAE) and behavioral observa-
tion audiometry (BOA), with reassessments as needed. 
Other tests, such as immittance testing and brainstem au-
ditory evoked potential (BAEP), were done for diagnostic 
purposes. Patients were referred to specialists if a diagnosis 
of hearing loss was made.
A Biologic AUDX 1 device was used for DPOAE 
testing. Positive results were adequate responses in three 
of four tested frequencies (5, 4, 3, and 2 kHz).12 Testing 
was done during sleep or in the absence of excessive 
movement; the microphone of the otoacoustic emissions 
analyzer was coupled to the outer acoustic meatus with 
a silicone olive.
Behavioral observation consisted of using non-
calibrated instruments (jingle bells and large agogo) to 
note attention to sounds, exacerbated responses, the co-
chleopalpebral reflex (CPR), startle, and the habituation 
phenomenon. Adequate responses were children with the 
CPR and habituation upon startle.13 
An Interacoustics AZ7 impedance meter was used in 
immittance testing; a type A tympanometric curve (Jerger14) 
indicated absence of conductive loss. Acoustic reflexes 
were evaluated in some children only, those not moving 
excessively, to support the diagnosis.
A Biologic device with the EP Potentials software 
was used for BAEP testing; the child was preferably in 
deep sleep, or else sedated. The stimuli were 21.1 clicks 
per second, through two registration channels, rarefaction 
polarity, starting at 90 and 80 dBHL. Silver electrodes on 
the mastoids, vertex and frontal region picked up the 
responses. Next, the supra-aural headphones were pla-
ced. Wave reproducibility was investigated at stronger 
intensities, which was then decreased gradually down 
to the electrophysiological threshold. The manufacturer’s 
(Biologic) reference values were applied as normal values 
for analyzing wave latency and interpeaks, according to 
the corrected age of each patient.15 BAEP were classified 
as to the type of response and the type, degree, site and 
onset of hearing loss.16 
The response variable was the presence of hearing 
loss; the independent variables were sex, type of delivery, 
gestational age, the 1 and 5-minute Apgar scores, weight 
and whether it was appropriate, small or large for the ges-
tational age, a family history of hearing loss in infancy, con-
genital infection (toxoplasmosis, rubella, cytomegalovirus 
(CMV) infection, herpes, and syphilis (TORCH infections), 
maternal HIV carrier, whether exchange transfusion was 
made, time in an incubator, and presence and degree of 
peri-intraventricular hemorrhage, leukomalacia, menin-
gitis, malformation, use of ototoxic drugs, mechanical 
ventilation, syndromes, use of recreational drugs and/or 
alcoholic beverages by the mother during pregnancy, and 
consanguinity of parents.
The Epi Info software was applied for calculating the 
sample. The assumptions were a 95% confidence interval 
and a 5% margin of error. The estimated hearing loss for 
similar populations in the literature was 6.3%.17 The calcu-
lated sample based on these parameters was 188 patients. 
Information gathered from the medical history and 
audiological testing was entered into a database developed 
in Epi Info version 2001 (Centers for Disease Control and 
Prevention, Atlanta, United States of America). The study 
variables were sex, gestational age, type of delivery, and 
the presence of risk factors for hearing loss in neonates and 
lactating infants. Descriptive data resulted from frequen-
cies and percentages of categorical variables, and central 
tendency measures (mean and median) and measures of 
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dispersion (standard deviation) for quantitative data. The 
response variable in this study was hearing loss.
Data analysis was a two-step process, starting with 
the univariate analysis. The chi-square test, Fisher’s exact 
test and the odds ratio were applied for comparing propor-
tions. Student’s t test was used for comparing the response 
variable and the categorical covariates when the usual 
assumptions of the model were met (normal distribution 
and homoscedasticity). Otherwise the Mann-Whitney test 
was applied. The Kolmogorov-Smirnov test was used to 
check the assumption of normality of the t-test, and the 
Levene test was applied to check for homocedasticity.18 
The covariates Apgar score and weight were analyzed ca-
tegorically and quantitatively. Only one form was included 
if both were statistically significant. For ease of interpre-
tation, the categorical variable was chosen in such cases.
Multivariate analysis consisted of a logistics regres-
sion model, which initially included all variables with a 
p-value ≤ 0.25 in the univariate analysis - those at least 
trending towards statistical significance. Next, a stepwise 
process was applied until only the statistically significant 
variables (p-value ≤ 0.05) were included in the model; 
the clinical relevance was also taken into account. The 
interactions among all covariates in the final regression 
model were tested. The software R (public domain) was 
applied for the multivariate analysis. 
The institutional review board approved this study 
(Opinion no. ETIC 271/05). The caretakers of newborn 
subjects signed a free informed consent form authorizing 
data gathering. 
RESULTS
The initial sample comprised 188 children of which 
the medical and family histories were taken. Two patients 
(1.1%) were excluded - they undertook hearing screening 
but not BAEP testing by the end of the data-gathering 
period, and their evaluation was therefore incomplete. 
Hearing loss was found in 12 infants (6.3%) of the sample. 
Unilateral hearing loss was detected in two of these infants 
(16.7%), and bilateral hearing loss was found in the other 
10 (83.3%). Among infants with hearing loss, three (25%) 
had retrocochlear disorders. These children with hearing 
loss were referred to otorhinolaryngological care and a 
speech therapy. 
The gestational age ranged from 25 to 37 weeks in 
the 186-subject sample; the median was 31 weeks. The 
weight ranged from 560 to 2,925 g; the median value was 
1,502.5 g. The 1’ Apgar score ranged from 1 to 9 (median 
- 7) and the 5’ Apgar score ranged from 3 to 10 (median 
- 9). Table 1 presents the main features of the prenatal 
period, birth and postnatal period.
One infant (0.5%) had congenital syphilis, one 
infant (0.5%) had congenital toxoplasmosis, and another 
infant (0.5%) had CMV infection. Five mothers (2.7%) 
were HIV-positive.
Table 2 shows that HIV-positive mothers and use of 
recreational drugs and/or alcohol by mothers correlated 
positively with hearing loss in infants. 
Very low birth weight infants tended to have worse 
results in hearing testing compared to those with higher 
birth weights. The presence of a family history of hearing 
loss in infancy increased the chance of an infant presenting 
hearing loss fivefold; any syndrome also present raised this 
chance of having hearing loss to 20 times the normal range. 
DISCUSSION
This study describes the prevalence of hearing loss 
and the features of children born in a tertiary reference 
hospital and monitored in an outpatient clinic for patients 
discharged from that hospital. The findings confirm the 
6.3% prevalence of hearing loss encountered previously 
in a survey of very low birth weight infants in Brazil using 
a similar method (DPOAE and BAEP testing).17 Other 




 Male 94 50,5
 Female 92 49,5
Delivery
 Normal 68 36,5
 Cesarean section 118 63,5
Weight/gestational age
 AGA 156 83,9
 SGA 29 15,6
 LGA 1 0,5
Family history of hearing loss
 Yes 15 8,1
 No 170 91,4
 Unclear 1 0,5
Peri-intraventricular hemorrhage
 Grade I 21 11,3
 Grade II 15 8,1
 Grade III 14 7,5
 None 132 73,1
Weight (grams)
 < 1,000 27 14,5
 1,000 to 1,499 66 35,5
 ≥ 1500 93 50,0
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studies of very low birth weight infants presented lower 
prevalence values, such as Gill et al. in 1998 (5.56% preva-
lence), and Roth et al. in 2006 (0.3% rate of sensorineural 
conditions).4,19
Other studies of newborn infants in neonatal in-
tensive care units show higher prevalence rates, which 
may be the result of multiple risk factors for hearing loss 
in this group.5,7,20
Variation among studies may be due to other 
prenatal variables, healthcare, and infections that may 
cause hearing loss. Other factors are the quality of life of 
a given population, access to adequate nutrition, and the 
level of culture.
A recent survey in the state of Bahia aimed to inves-
tigate the etiology of hearing loss and found that the main 
cause was rubella of the mother, followed by pyogenic 
meningitis, idiopathic causes, prematurity, hereditary fac-
tors, neonatal jaundice, and others such as chronic otitis 
media and ototoxicity.21 In our data, 0.5% of infants had 
syphilis, congenital toxoplasmosis or CMV infection.
Congenital toxoplasmosis, which is frequent in 
Brazil, may cause hearing loss. It may develop subclini-
cally, compromising the early diagnosis of hearing loss. 
A recent survey in the city of Belo Horizonte showed that 
the prevalence of congenital toxoplasmosis is 1 for every 
1,590 live births. Patients with this disease were referred 
for audiological investigation, the results of which showed 
that 21.1% of these infants had sensorineural hearing loss 
and 10.5% had conduction hearing loss.22
Hearing loss in CMV infection is generally progres-
sive. The infant with CMV infection in this study acquired 
the disease after a blood transfusion; statistical significance, 
however, was not attained. This is probably because the 
sample of mothers with prenatal CMV serology is low 
(only 44 of 186 took this test), resulting in a lesser effect 
on the data. Additionally, the first signs of hearing loss 
may present late; thus, a study monitoring the development 
of hearing and language in children may show a higher 
prevalence of hearing loss caused by CMV infection.
 A systematic review of studies on congenital CMV 
infection revealed that if the prevalence at birth is 0.7% and 
the risk of bilateral moderate to profound sensorineural 
hearing loss is 3 to 5%, the risk of a child developing per-
manent bilateral hearing loss because of CMV infection is 
0.21 to 0.35 per 1,000 births.23 A 10-year prospective study 
on sensorineural hearing loss in children with congenital 
CMV found a 0.53% prevalence rate in the population. Of 
those with infection, 5.4% were asymptomatic and 94.6% 
Table 2. Comparison of altered hearing and risk factors for hearing loss in high-risk infants
Covariate
Final result on hearing
p-value odds ratio 95% CIAltered Normal
 n % n %
HIV-positive mother
 Yes 2 16,7 3 1,7 *0,034 11,4 1,2 a 100,4
 No 10 83,3 171 98,3 ... 1,0 ...
Drugs/alcohol use by mother
 Yes 4 33,3 24 13,9 *0,048 4,1 0,9 a 18,3
 No 8 66,7 149 86,1 ... 1,0 ...
Weight (grams)
 < 1,500 9 75,0 84 48,3 0,073 3,2 0,8 a 15,6
 ≥ 1,500 3 25,0 90 51,7 ... 1,0 ...
Family history
 Yes 3 25,0 12 6,9 *0,061 4,5 0,8 a 21,8
 No 9 75,0 161 93,1 ... 1,0 ...
Syndrome
 Yes 1 8,3 0 0,0 *0,064 ... ...
 No 11 91,7 174 100,0 ... 1,0 ...
Cytomegalovirus infection
 Yes 1 25,0 0 0,0 *0,090 ... ...
 No 3 75,0 40 100,0 ... 1,0 ...
Key: HIV (human immunodeficiency virus) *: Fisher’s exact test
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were symptomatic. Hearing test detected a 22% rate of 
sensorineural hearing loss. Late onset hearing loss was 
present in 5% of cases; fluctuating hearing was found in 
16% of cases, and progressive hearing loss occurred in 
11% of cases. These data showed the need to monitor the 
hearing of infants with congenital CMV infection.24
Our study showed a statistically significant differen-
ce in infants of HIV-positive mothers. However, another 
study of hearing in infants of HIV-positive mothers com-
pared with those of HIV-negative mothers concluded that 
the risk of sensorineural hearing loss was not higher in 
the former group.25
Other authors have suggested that AIDS should 
be considered a risk factor for peripheral and/or central 
hearing loss.11 HIV-positive children tended to have hea-
ring disorders of central causes; their acquisition of sound 
location ability was also compromised.26
The study method included DPOAE testing in two 
or three steps, and immittance and BAEP tests (see Fig. 
1). A recent study of 4,519 infants aged not more than 
3 years concluded that DPOAE testing (using the same 
equipment and protocol of the present study) in several 
steps and monitoring guidelines are useful for detecting 
hearing loss.27
This study started in 2006; at that point, the most 
recent JCIH recommendations were those of 2000. For 
completeness, our study included the JCIH indicators of 
the years 1994 and 2000. New JCIH recommendations 
were published on October 2007; these guidelines em-
phasized that high-risk children should be evaluated using 
BAEP testing because of the risk of auditory neuropathy.28 
Children with altered initial tests (OAE, BOA) but with no 
conduction disorders of sound stimuli (immittance testing), 
and children with normal results in the initial tests but at 
some risk of central hearing loss (elevated bilirubin levels 
requiring exchange transfusion, HIV-positive mother, 
TORCH infections) underwent BAEP testing. 
This method enabled the detection of three cases 
of retrocochlear disorders in the study sample, thereby 
underlining the concern with such conditions in infants 
with risk factors. The prevalence of these disorders in 
children with profound hearing loss was 0.94%;29 further-
more, retrocochlear disorders may also occur in children 
without risk factors.30
 Monitoring of children aged up to 2 years may also 
reveal cases of progressive or delayed onset hearing loss, 
given that the study sample consisted of high-risk infants 
for all types of hearing loss.
CONCLUSION
This study aimed to detect the prevalence of audi-
tory disorders in children exposed to several risk factors, 
because it is thought that the prevalence of hearing loss is 
high in this population group. In these subjects, multiple 
factors may result in progressive or delayed onset neonatal 
or postnatal hearing loss, which should be assessed and 
monitored in a hearing screening program. 
Timely diagnosis and interventions for speech deve-
lopment are not the reality throughout Brazil in most cases 
of prelingual hearing loss. The population and healthcare 
professionals involved in childcare should be made aware 
of the impact of hearing loss; this could result in increased 
adhesion to neonatal screening programs. 
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